Michael Benkowitz - Dec 29, 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
PRESIDENT AND COO
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Dec 29, 2022
Transactions value $
-$2,196,450
Form type
4
Date filed
1/3/2023, 03:30 PM
Previous filing
Dec 23, 2022
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise -$817K -5K -40.48% $163.30 7.35K Dec 29, 2022 Direct F1
transaction UTHR Common Stock Sale -$1.38M -5K -68% $275.99 2.35K Dec 29, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -5K -13.44% $0.00 32.2K Dec 29, 2022 Common Stock 5K $163.30 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.